Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 31,126 | 32,448 | 32,985 | 35,627 | 40,991 |
| Cost of Goods | 8,889 | 11,177 | 9,721 | 7,060 | 4,772 |
| Gross Profit | 22,237 | 21,271 | 23,264 | 28,567 | 36,219 |
| Operating Expenses | 26,743 | 25,785 | 56,314 | 256,898 | 24,571 |
| Operating Income | -3,617 | -4,337 | -32,329 | -228,271 | 12,420 |
| Interest Expense | 758 | 757 | 755 | 752 | 751 |
| Other Income | 850 | 716 | 1,179 | 138 | 661 |
| Pre-tax Income | -3,525 | -4,378 | -31,905 | -228,885 | 12,330 |
| Income Tax | 149 | 132 | 25,479 | 50,659 | 3,860 |
| Net Income Continuous | -3,674 | -4,510 | -57,384 | -279,544 | 8,470 |
| Net Income | $-3,674 | $-4,510 | $-57,384 | $-279,544 | $8,470 |
| EPS Basic Total Ops | -0.04 | -0.05 | -1.33 | -3.42 | 0.15 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -1.33 | -3.42 | 0.15 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -1.31 | -3.42 | 0.13 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -1.30 | -3.42 | 0.12 |
| EPS Diluted Before Non-Recurring Items | -0.04 | 0.03 | 0.08 | N/A | N/A |
| EBITDA(a) | $3,202 | $1,466 | $-27,316 | $-217,812 | $19,001 |